Eliem Therapeutics, Inc. (NASDAQ:ELYM – Get Free Report)’s share price shot up 5.4% during trading on Friday . The company traded as high as $4.96 and last traded at $4.85. 323,001 shares changed hands during trading, a decline of 34% from the average session volume of 486,688 shares. The stock had previously closed at $4.60.
Eliem Therapeutics Stock Up 1.6%
The stock has a market cap of $146.68 million, a P/E ratio of -9.30 and a beta of -0.39. The firm has a 50 day simple moving average of $2.38 and a 200-day simple moving average of $1.98.
Eliem Therapeutics Company Profile
Eliem Therapeutics, Inc is a clinical‐stage biotechnology company focused on the development of novel therapeutics for the treatment of neurological and neuropsychiatric disorders. The company’s scientific approach is centered on proprietary peptide and small‐molecule drug candidates designed to modulate central nervous system pathways. By leveraging targeted delivery and receptor‐specific activity, Eliem seeks to address unmet medical needs in areas such as pain management, spasticity and other debilitating sequelae of spinal cord injury.
The company’s most advanced program, ELI-200, is being investigated as a potential treatment for spasticity and neuropathic pain associated with spinal cord injury.
Featured Articles
- Five stocks we like better than Eliem Therapeutics
- Wall Street Stockpicker Names #1 Stock of 2026
- ALERT: Drop these 5 stocks before January 2026!
- The $650 Million Bet on AI’s Future
- Nvidia x 1,000,000
- GOLD ALERT
Receive News & Ratings for Eliem Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eliem Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
